Ajanta Pharma Ltd. board on Monday approved its first interim dividend of Rs 28 per share for the financial year 2026. The record date for the purpose of determining the entitlement of the ...
Ajanta Pharma said the growth was driven by strong performance in its branded generics and US generics businesses. Revenue ...
Hong Kong Exchanges and Clearing (HKEX) will launch five new weekly stock options and a Hang Seng Biotech Index Futures ...
Capital Market on MSN
Glenmark Pharmaceuticals Ltd spurts 0.02%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1891.5, up 0.02% on the ...
With the FTSE 100 hitting new highs last month, Mark Hartley considers where global stock markets may be heading next – and ...
In a significant development, Syndax Pharmaceuticals Inc. has announced a new clinical study titled ‘A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With ...
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative ...
George Tidmarsh, who resigned Sunday, is accused in a lawsuit of seeking a bribe and defaming a drug.
And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...
Square Pharmaceuticals, the country's leading drug manufacturer, reported a 15% rise in consolidated net profit to Tk2,397 crore for FY25, driven by strong performances from its subsidiaries and ...
AptarGroup stock faces a 25% drop and growth headwinds, but valuation is improving. Learn if ATR offers a compelling ...
Intellia Therapeutics is featured in Cathie Wood's portfolio and has a high Wall Street price target. The company's leading candidates look somewhat promising, but one of them just hit a major setback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results